Metamark Genetics, Inc. Determined to Conquer Cancer
 
 
 
About Us R&D - Research and Development Media & News Careers Contact Us
 
 
About Us
Press Release
Overview
Media Watch
 
Metamark
believes that greater knowledge of tumor cell biology and behavior will be a major advance in designing optimized treatment strategies for individual patients and will improve survival and reduce morbidity from unnecessary treatments.
 
 

 

In the News

April 30th, 2013
Metamark Genetics Board of Directors Appoints Shawn M. Marcell President
and Chief Executive Officer
Read More >
December 30th, 2012
Metamark Genetics Announces the Resignation of Dr. Lynda Chin from the Board
Read More >
November 5, 2012
Metamark Genetics Completes $13 Million Series B Financing;
Announces Leadership Changes
Read More >
April 4, 2012
Metamark Genetics Completes Proof-of-Concept for
Protein-based Prostate Cancer Test
Read More >
December 19th, 2011
Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
Read More >
July 11th, 2011
Metamark Genetics Announces Cancer Cell Study Highlighting Discovery
of Key Molecules that Drive Progression of Malignant Melanoma in Humans
Read More >
June 30th, 2011
Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
Read More >
February 2nd, 2011
Metamark Genetics Announces Landmark Prostate Cancer Study Published in Nature
Read More >
December 20th, 2010
Metamark and HistoRx Announce Licensing Agreement for AQUA® Technology
Read More >
November 5th, 2010
Metamark Genetics, Inc. Announces New Chief Executive Officer
Read More >
September 23rd, 2010
Metamark Genetics, Inc. Announces Three New Board Members
Read More >
September 16th, 2010
Metamark Genetics, Inc. Announces New Chief Scientific Officer
Read More >
July 13th, 2010
Metamark Genetics, Inc. Completes $22 Million Series B Financing to Advance Pipeline of Innovative Function-Based Prognostic Assays for Early Stage Cancers
Read More >
November 18, 2009
Metamark Genetics, Inc. Founder Dr. Raju Kucherlapati hosts the fifth annual Personalized Medicine Conference
Read More >
March 10, 2009
Szent-Györgyi Prize for Progress in Cancer Research awarded to Metamark Genetics, Inc. co-Founder Dr. Ronald DePinho
Read More >
February 7, 2009
Metamark Genetics, Inc. Scientific Founder Dr. Lynda Chin chairs Translation of the Cancer Genome conference
Read More >
October 13, 2008
Metamark Genetics, Inc. co-Founder Dr. Raju Kucherlapati elected into the Institute of Medicine
Read More >
 

Top |  Download Adobe Acrobat PDF Reader